Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Autoimmune Diseases Autoimmune Diseases for January/February 2020 Meta-Analysis Eyes Impact of Adherence to HCQ Among SLE Patients, More must reads Autoimmune Diseases for November/December 2019 VEDOSS Study Describes Predictors of Progression to Systemic Sclerosis, TULIP Trials Show Clinical Benefit of Anifrolumab for SLE, Glucocorticoids Linked to Damage Accrual in SLE Regardless of Disease Activity, Fewer people are dying from systemic sclerosis at younger ages, Vitiligo: First-Ever RCT is Smashing Success, More must readsAutoimmune Diseases for September/October 2019 Systemic Sclerosis Raises Risk of Breast Cancer, Lung Cancer, Melanoma, Low disease activity a valid target in early SLE, investigators say, Zostavax Proves Safe, Effective in Patients With Nonactive SLE, Study aims to define symptoms of Sjögren’s syndrome secondary to SLE, More must readsAutoimmune Diseases for July/August 2019 Cutaneous Reaction to AEDs? Think Autoimmune Epilepsy, Repeated ANA Testing After Negative Result of Little Diagnostic Value, Tocilizumab Preserves Lung Function in Systemic Sclerosis, Genetic Variant Could Dictate Rituximab Response in Lupus, More must readsAutoimmune Diseases for March/April 2019 Increased Mortality From Scleroderma in African Americans, BTK Inhibitor Calms Pemphigus Vulgaris With Low-Dose Steroids, More must readsPages« first 1 2 3 last »
